SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

BRIEF-Kyverna Therapeutics Announces Completion Of BLA Submission For Miv-Cel In Stiff Person Syndrome And Reports Third Quarter 2026 Financ

BRIEF-Kyverna Therapeutics Announces Completion Of BLA Submission For Miv-Cel In Stiff Person Syndro

KYTX

Related stories